Related Experiment Videos

Mixed connective tissue disease in childhood: a nationwide retrospective study in Japan

S Yokota1, T Imagawa, S Katakura

  • 1Department of Pediatrics, Yokohama City University School of Medicine, Japan.

Acta Paediatrica Japonica : Overseas Edition
|April 1, 1997
PubMed

Insights

This study confirms Raynaud's phenomenon and anti-RNP antibodies are key for diagnosing mixed connective tissue disease (MCTD) in children. MCTD exhibits distinct clinical and lab features, differentiating it from systemic lupus erythematosus.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Connective Tissue Diseases

Background:

  • Mixed Connective Tissue Disease (MCTD) is a complex autoimmune disorder.
  • Accurate diagnosis and differentiation from other autoimmune diseases are crucial for effective management.

Purpose of the Study:

  • To analyze the clinical and laboratory characteristics of MCTD in a pediatric cohort.
  • To confirm diagnostic markers and assess MCTD's distinctness from Systemic Lupus Erythematosus (SLE).

Main Methods:

  • Nationwide prospective study involving 66 children diagnosed with MCTD.
  • Analysis of clinical symptoms (e.g., Raynaud's phenomenon, finger swelling, facial erythema, polyarthralgia).
  • Evaluation of laboratory findings (e.g., anti-RNP antibody, rheumatoid factor, hypergammaglobulinemia, myogenic enzymes).

Main Results:

  • Diagnostic significance of Raynaud's phenomenon and anti-RNP antibodies was confirmed.
  • Variable presence of other symptoms like finger swelling, facial erythema, and polyarthralgia.
  • Laboratory findings including positive rheumatoid factor, hypergammaglobulinemia, and elevated myogenic enzymes were observed.

Conclusions:

  • MCTD in children presents with specific clinical and laboratory profiles.
  • These characteristics significantly differ from those observed in Systemic Lupus Erythematosus.
  • The findings support MCTD as an independent disease entity.

Related Concept Videos